ES2057006T3 - Derivados sulfoamino de sulfatos de controitina, de sulfato de dermatano y de acido hialuronico y sus propiedades farmacologicas. - Google Patents

Derivados sulfoamino de sulfatos de controitina, de sulfato de dermatano y de acido hialuronico y sus propiedades farmacologicas.

Info

Publication number
ES2057006T3
ES2057006T3 ES89107615T ES89107615T ES2057006T3 ES 2057006 T3 ES2057006 T3 ES 2057006T3 ES 89107615 T ES89107615 T ES 89107615T ES 89107615 T ES89107615 T ES 89107615T ES 2057006 T3 ES2057006 T3 ES 2057006T3
Authority
ES
Spain
Prior art keywords
derivatives
hyaluronic acid
controitin
sulfoamine
sulphates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89107615T
Other languages
English (en)
Inventor
Benitu Casu
Giangiacomo Torri
Annamaria Naggi
Marisa Mantovani
Rodolfo Pescador
Roberto Porta
Giuseppe Prino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Crinos Industria Farmacobiologica SpA
Original Assignee
Crinos Industria Farmacobiologica SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crinos Industria Farmacobiologica SpA filed Critical Crinos Industria Farmacobiologica SpA
Application granted granted Critical
Publication of ES2057006T3 publication Critical patent/ES2057006T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06—Aminosugars
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE DESCUBREN NUEVOS DERIVADOS OBTENIDOS DE SULFATO CARTILAGINOSO, SULFATO DERMICO Y ACIDO HIALURONICO, TENIENDO UNA RELACION MOLAR ENTRE LOS GRUPOS DE SULFATO Y LOS GRUPOS CARBOXILICOS SIMILAR A LA HEPARINA Y CARACTERIZADOS ADEMAS POR POSEER, COMO LA HEPARINA, EL GRUPO SULFOAMINO EN EL ATOMO DE CARBONO EN LA HEXOSAAMINA DE POSICION 6. LOS NUEVOS COMPUESTOS MUESTRAN UNA MUY IMPORTANTE ACTIVIDAD ANTI COAGULANTE EN COMPARACION CON LOS MUCOPOLISACARIDOS ORIGINALES, SIENDO ESTA ACTIVIDAD SIMILAR Y PARA ALGUNOS DERIVADOS COMPARABLE CON LA DE LA HEPARINA. ADEMAS, A DIFERENCIA DE LO QUE SUCEDE NORMALMENTE SOBRE EL SULFATADO DE LOS SULFOMUCOPOLISACARIDOS, LA ACTIVIDAD ANTICOAGULANTE DE LOS NUEVOS COMPUESTOS ES INSIGNIFICANTE O DE ALGUN MODO MUY REDUCIDA. EL COMPUESTO DE LA PRESENTE INVENCION TIENE USO EN LA TERAPIA DE LA ARTERIOESCLEROSIS.FIG 1.
ES89107615T 1988-05-02 1989-04-27 Derivados sulfoamino de sulfatos de controitina, de sulfato de dermatano y de acido hialuronico y sus propiedades farmacologicas. Expired - Lifetime ES2057006T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20412/88A IT1217458B (it) 1988-05-02 1988-05-02 Sulfoamino derivati di condroitin solfati,del dermatan solfato e dell' acido ialuronico e loro proprieta' farmacologiche

Publications (1)

Publication Number Publication Date
ES2057006T3 true ES2057006T3 (es) 1994-10-16

Family

ID=11166540

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89107615T Expired - Lifetime ES2057006T3 (es) 1988-05-02 1989-04-27 Derivados sulfoamino de sulfatos de controitina, de sulfato de dermatano y de acido hialuronico y sus propiedades farmacologicas.

Country Status (11)

Country Link
US (1) US5008253A (es)
EP (1) EP0340628B1 (es)
JP (1) JPH01318002A (es)
KR (1) KR900018129A (es)
AT (1) ATE109163T1 (es)
AU (1) AU618346B2 (es)
CA (1) CA1307525C (es)
DE (1) DE68917009T2 (es)
ES (1) ES2057006T3 (es)
IT (1) IT1217458B (es)
PT (1) PT90414B (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8826448D0 (en) * 1988-11-11 1988-12-14 Thrombosis Res Inst Improvements in/relating to organic compounds
DK0421508T3 (da) * 1989-10-04 1994-04-11 Akzo Nobel Nv Sulfateret glycosaminoglycuronan med antithrombotisk aktivitet
FR2655267B1 (fr) * 1989-12-04 1992-04-03 Roussel Uclaf Nouveau derive sulfate du galactanne extrait de klebsiella, procede de preparation, application a titre de medicaments et compositions pharmaceutiques le renfermant.
WO1991015217A1 (en) * 1990-04-06 1991-10-17 Washington University Anticoagulant oligosaccharides
FR2669932B1 (fr) * 1990-12-03 1994-07-01 Sanofi Sa Nouvel heparosane-n,o-sulfate, son procede de preparation et les compositions pharmaceutiques qui le contiennent.
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
GB2286193A (en) * 1991-03-28 1995-08-09 Italfarmaco Spa Anticoagulants and processes for preparing such
US5605938A (en) * 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
US5705178A (en) * 1991-05-31 1998-01-06 Gliatech, Inc. Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
US5234914A (en) * 1991-06-11 1993-08-10 Patent Biopharmaceutics, Inc. Methods of treating hemorrhoids and anorecial disease
WO1994017538A2 (en) * 1993-01-21 1994-08-04 Mayo Foundation For Medical Education And Research Microparticle switching devices
US5654006A (en) * 1993-02-12 1997-08-05 Mayo Foundation For Medical Education And Research Condensed-phase microparticle composition and method
US5753261A (en) * 1993-02-12 1998-05-19 Access Pharmaceuticals, Inc. Lipid-coated condensed-phase microparticle composition
US5820879A (en) * 1993-02-12 1998-10-13 Access Pharmaceuticals, Inc. Method of delivering a lipid-coated condensed-phase microparticle composition
ITPD940054A1 (it) * 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
US5690961A (en) * 1994-12-22 1997-11-25 Hercules Incorporated Acidic polysaccharides crosslinked with polycarboxylic acids and their uses
IT1290814B1 (it) * 1997-03-24 1998-12-11 Istituto Scient Di Chimica E B Glicosaminoglicani aventi elevata attivita' antitrombotica
ATE229038T1 (de) 1997-04-04 2002-12-15 Fidia Advanced Biopolymers Srl N-sulfatierte hyaluronsäureverbindungen, ihre derivate und verfahren zu ihrer herstellung
DE19813234A1 (de) * 1998-03-26 1999-09-30 Knoell Hans Forschung Ev Verfahren zur Herstellung hochsulfatierter Hyaluronsäuren
US20030104601A1 (en) * 1999-04-01 2003-06-05 Deangelis Paul L. Chondroitin synthase gene and methods of making and using same
US7223571B2 (en) * 1998-04-02 2007-05-29 The Board Of Regents Of The Universtiy Of Oklahoma Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same
US20080108110A1 (en) * 1998-04-02 2008-05-08 Deangelis Paul L Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same
US20060188966A1 (en) * 1998-04-02 2006-08-24 Deangelis Paul L Natural, chimeric and hybrid glycosaminoglycan polymers and methods of making and using same
KR100530196B1 (ko) 1998-04-30 2005-11-22 마루하 가부시키가이샤 구조내 글루쿠론산 유도체 및 글루코사민 유도체를 갖는화합물, 그의 제법 및 그의 용도
US20020086852A1 (en) * 1998-05-14 2002-07-04 Cantor Jerome O. Method for treating respiratory disorders associated with pulmonary elastic fiber injury
ITPD980169A1 (it) 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
US7642071B2 (en) 1999-04-01 2010-01-05 The Board Of Regents Of The University Of Oklahoma Methods of expressing gram-negative glycosaminoglycan synthase genes in gram-positive hosts
US20040161476A1 (en) * 2003-02-19 2004-08-19 Hahn Sungtack Samuel Cystitis treatment with high dose chondroitin sulfate
ITPD20050056A1 (it) 2005-03-02 2006-09-03 Fidia Farmaceutici Derivati ammidici del'acido ialuronico in osteoartrosi
BRPI0909849A2 (pt) 2008-04-04 2015-10-06 Univ Utah Res Found éteres semi-sintéticos de glicosaminoglicosanos e métodos para fazê-los e usá-los
IT1397247B1 (it) * 2009-05-14 2013-01-04 Fidia Farmaceutici Nuovi agenti regolatori dell'attivita' citochinica
US8546353B2 (en) * 2010-05-06 2013-10-01 Glykos Finland Oy Compounds and combinations
US9522162B2 (en) 2011-03-23 2016-12-20 University Of Utah Research Foundation Methods for treating or preventing urological inflammation
EP2928500B1 (en) 2012-12-04 2019-03-06 Phosphorex Inc. Microparticles and nanoparticles having negative surface charges
JP6063103B1 (ja) * 2015-03-31 2017-01-18 生化学工業株式会社 グリコサミノグリカンの硫酸化方法
WO2018053111A1 (en) 2016-09-15 2018-03-22 University Of Utah Research Foundation In situ gelling compositions for the treatment or prevention of inflammation and tissue damage
CN111228653A (zh) 2018-11-13 2020-06-05 格莱科米拉治疗公司 用电离辐射加强癌症治疗的方法
CN111662394B (zh) * 2019-03-05 2022-11-04 中国医学科学院药物研究所 硫酸软骨素多糖半合成制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB838709A (en) * 1955-09-22 1960-06-22 Upjohn Co Improvements in or relating to aminoalcohol-n-sulphonic acid compounds
US3405120A (en) * 1966-01-27 1968-10-08 Green Cross Corp Low molecular chondroitin sulfate and method for manufacturing the same
FR2504535B1 (fr) * 1981-04-28 1987-08-14 Choay Sa Disaccharides derives d'un acide uronique et d'une glucosamine et compositions pharmaceutiques les contenant pour le controle de la coagulation sanguine
US4818816A (en) * 1981-04-28 1989-04-04 Choay, S.A. Process for the organic synthesis of oligosaccharides and derivatives thereof
EP0838709A3 (de) * 1996-09-30 1999-07-28 Siemens Aktiengesellschaft Anordnung zur Erzeugung einer Umsetzung zwischen Lichtstrahlen kleineren Strahlquerschnitts und einem Lichtstrahl grösseren Strahlquerschnitts

Also Published As

Publication number Publication date
CA1307525C (en) 1992-09-15
US5008253A (en) 1991-04-16
EP0340628A3 (en) 1990-01-24
JPH01318002A (ja) 1989-12-22
KR900018129A (ko) 1990-12-20
EP0340628B1 (en) 1994-07-27
IT1217458B (it) 1990-03-22
ATE109163T1 (de) 1994-08-15
PT90414A (pt) 1989-11-30
EP0340628A2 (en) 1989-11-08
IT8820412A0 (it) 1988-05-02
AU618346B2 (en) 1991-12-19
AU3392289A (en) 1989-11-02
DE68917009D1 (de) 1994-09-01
PT90414B (pt) 1994-08-31
DE68917009T2 (de) 1994-11-10

Similar Documents

Publication Publication Date Title
ES2057006T3 (es) Derivados sulfoamino de sulfatos de controitina, de sulfato de dermatano y de acido hialuronico y sus propiedades farmacologicas.
ES2054988T3 (es) Quinuclidinas, su empleo como medicamentos y procedimiento para su produccion.
NO912397D0 (no) Polypeptid-polymerkonjugater som er aktive ved saarlegning.
IT1217453B (it) Procedimento per la produzione di perfluoropolieteri a peso molecolare controllato,aventi gruppi terminali perfluoroalchilici o perfluorocloroalchilici
DE3864188D1 (de) Kondom.
DE3486341D1 (de) Derivate von Dextran mit antikoagulierenden und antikomplementären Eigenschaften, ihre Herstellung und ihre biologischen Anwendungen.
PT89923B (pt) Processo para a preparacao de variantes da hiridina
ATE143810T1 (de) Hepatozytwachstumsfaktor enthaltende mittel
DE59008005D1 (de) Verfahren zur Herstellung von hochmolekularen Copolyarylensulfiden.
BR8905138A (pt) Limpador de para-brisa com movimento translatorio,particularmente para o vidro dianteiro de um automovel
ES2045822T3 (es) Cable aereo de fibra optica.
ES2104598T3 (es) Uso del cofactor ii de heparina modificado.
DK0500800T3 (da) Antohæmostatiske Faktor VII-peptider
ATE81980T1 (de) Pharmazeutisches kombinationspraeparat sowie dessen herstellung und verwendung.
ES470323A1 (es) Reflector para vehiculo automovil o analogo
ATE80615T1 (de) 2-methyl-5-t-butyl-thiophenol, dessen herstellung und verwendung.
ATE172716T1 (de) Arylbenzoylguanidine
DE68918353D1 (de) Herstellung von geschäumten Polymerstrukturen.
FI890416A0 (fi) Flytfoerbaettrande medel, foerfarande foer framstaellning daerav samt anvaendning daerav.
ES2033299T3 (es) Material compuesto para uso medico o paramedico, particularmente ortopedico, y metodo para su fabricacion.
FI896214A0 (fi) Plastkompositbalk eller -pelare och foerfarande foer framstaellning av en plastkompositbalk eller -pelare.
ES2073159T3 (es) Procedimiento para la preparacion de un copoli(sulfuro de arileno) que tiene una proporcion disminuida de radicales disulfuro.
DE69120158D1 (de) Hirudin-Analoge mit Antiblutplättchen-Aktivität
DE69309441D1 (de) Verstärkte formmassen mit verbesserten kristallisationseigenschaften
SE8501875L (sv) Balk av med ett fibermaterial armerad plast

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 340628

Country of ref document: ES